Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors - a single center experience . Clinics, [S. l.], v. 70, n. 8, p. 550–555, 2015. DOI: 10.6061/clinics/2015(08)04. Disponível em: https://www.revistas.usp.br/clinics/article/view/102011.. Acesso em: 13 may. 2024.